Epidemiological and laboratory investigations have shown that toluene and styrene are toxic compounds that lead to impairment of the nervous system. To quantitate toluene and styrene in biological samples, liquid-liquid phase, headspace (HS), and solid-phase microextraction (SPME) methods are generally used. Most of these methods are not sensitive enough for applications involving small sample volumes. Here, we present a method for quantitative analysis of low concentrations of styrene and toluene in very small volumes of biological samples using HS-SPME and gas chromatography (GC) equipped with a flame-ionization detector. The method was developed by optimizing operating parameters that affect the HS-SPME-GC process [i.e., desorption time (30 s), depth of the fiber in the GC injection port (3.7 cm), adsorption time (4 rain), and adsorption temperature (room temperature)]. It has a wide range of linearity (0.5-500 ng/10 pL), high precision (coefficient of variation < 5%), good accuracy (deviation < 11%), and low detection limits of 0.13 and 0.08 ng/10 pL for styrene and toluene in serum, respectively. This analytical technique can be applied to the estimation of styrene and toluene in small volumes of biological fluids (blood, serum, and perilymph) and tissues of low lipid content (cochlea).
Introduction
Styrene and toluene are used extensively in the production of polymer surface coatings, resins, and synthetic rubber, where worker exposure can occur. The quantitative determination of these organic solvents in biological fluids is of importance as they are highly volatile and hazardous to human health. Human and animal studies suggest that chronic expo-* Author to whom correspondence should be addressed. sure to styrene and toluene are implicated primarily in central and peripheral nervous system disorders and loss in hearing activity (1) (2) (3) (4) (5) (6) .
Over the last few decades, several research groups have developed analytical methods for analyzing styrene and toluene in biological samples using liquid-liquid extraction (LLE), headspace (HS), and HS-solid-phase microextraction (SPME) techniques (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) . Ramsey et al. (15) and Tornero-Velez et al. (7) extracted styrene from 5-mL homogenized whole blood samples by LLE and gas chromatography (GC), and Colin et al. (8) measured styrene from 100 IJL of serum, liver, or kidney homogenate by LLE and reversed-phase high-pressure liquid chromatography (HPLC). Apostoli et al. (16) and Prieto et al. (9) measured toluene in 5 mL of whole blood samples using the purge-and-trap technique. Lee et al. (12) and Alegretti et al. (20) measured toluene in 0.5 and 2 mL of whole blood, respectively, using HS-SPME. Fustinoni et al. (11) assessed 2 mL of urine for toluene concentrations using HS-SPME. Campo et al. (18) attempted to quantitate styrene in organ of corti using HS-SPME, but were constrained by the small size of the sample (< 2 rag). Previously developed analytical techniques that are generally employed for the analysis of styrene and toluene in biological matrices use sample volumes ranging from 0.5 to 5 mL and are not sensitive enough for applications involving very small sample volumes.
The current paper describes an HS-SPME-GC method developed to analyze low concentrations of styrene and toluene in very small volumes of biological samples. The method is based on Markelov and Guzowski's full evaporation HS GC technique, which uses a very small sample size to eliminate the need for sample pretreatment and to overcome the interference of other compounds in the biological matrix (21) . Our HS-SPME-GC method has been successfully used by Chen et al. (22) in a study aimed at determining the cellular mechanism underlying styrene ototoxicity.
Methods and Materials

Chemicals and equipment
HPLC-grade styrene and toluene were obtained from Sigma-Aldrich (St. Louis, MO). Methanol, HPLC-grade, was procured from EM Science (Gibbstown, N J). Sheep serum and whole blood were purchased from Quad Five (Ryegate, MO). For interference studies, lipid emulsions were prepared using linoleic acid (99% purity) obtained from Sigma-Aldrich. Standard solutions were prepared using 10-and 500-1JL gas-tight syringes obtained from Hamilton (Reno, NV).
The SPME manual fiber holder and a carboxeneTM-polydimethylsiloxane microextraction fiber were purchased from Supelco (Bellefonte, PA). Before use, the fiber was conditioned by heating at 300~ in the GC injector for 2 h as per the manufacturer's instructions. Clear 10-mL glass vials and corresponding stainless steel screw-caps lined with PTFE-faced silicone septum were also purchased from Supelco.
The chromatographic analysis was performed using an HP 6890 GC (Agilent Technologies, Santa Clara, CA) equipped with an electronic pneumatically controlled split/splitless injector and a flame-ionization detector. Target analytes were resolved using an SPBTM-624 fused silica capillary column (30 m x 0.25-mm i.d. x 1.4-]Jm film thickness) purchased from Supelco. Chromatography conditions were as follows: injection port temperature 250~ detector temperature 250~ and an initial oven temperature of 35~ held for 1 min, followed by a 5~ ramp to 150~ and held at 150~ for 2 min. Injections with the SPME fiber were made in the splitless mode using a narrow SPMEGC inlet liner (78.5 mmx 6.5 mmx 0.75 mm) purchased from Supelco. Ultra-high-purity helium was used as the carrier gas at constant flow rate of 1.5 mL/min.
Method development and analytical method validation
Method development. Optimization studies were conducted using serum as the sample matrix. The standard reference solutions were prepared by serial dilutions of a 10 mg/mL styrene and toluene standard in methanol. An intermediate standard solution of 10 IJg/mL was prepared in blood and serum. The standard solutions for method optimization and validation studies were prepared by serial dilution of the 10 IJg/mL intermediate standard into blood or serum. A 10-]~L aliquot of these standard solutions was used in subsequent experiments.
For all experiments, samples were equilibrated in the HS vial for at least 15 min prior to sampling the HS with the SPME fiber. At the end of each run, the fiber was reinserted into the injection port for an additional 30 min to ensure that no carryover occurred in subsequent sampling. Five operating parameters were evaluated in the following order: desorption time, depth of the fiber in the GC injection port during desorption, adsorption time, adsorption temperature, and sample volume. During optimization, one parameter was varied at a time while keeping the other parameters constant. Once a parameter was optimized, its optimized condition was used in the evaluation of the remaining parameters and for subsequent analytical validation studies. The analytical performance of the method was studied with respect to linearity, precision, accuracy, recovery, and interference.
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Method validation. Linearity studies were conducted in both serum and whole blood. The linearity of the method was determined for both styrene and toluene in the range of 0.5-500 ng/10 ]JL. From a stock of 10 mg/mL of styrene and toluene in methanol, standard concentrations of the analytes in serum and whole blood were prepared at room temperature by volumetric serial dilution. Linear regression analysis was performed to estimate the slope, intercept, and regression coefficient for the plots of peak area against analyte concentration.
The precision and accuracy of the method were studied by analyzing three standards: 1, 10, and 100 ng/10 IJL. For each standard concentration, five aliquots of approximately 500 IJL were prepared. The intraday precision and accuracy were determined by analyzing 1 aliquot 10 times on the same day (n = 10). Interday precision and accuracy were determined over a period of five days by thawing an aliquot each day and then analyzing it in triplicate (n = 3). The precision of the method was expressed as coefficient of variation (% CV). Accuracy was expressed as the percentage of deviation between the true and measured values.
The minimal detection limits (MDL) and minimal quantitation limits (MQL) of styrene and toluene in whole blood and serum were determined using the protocol outlined by U.S. Environmental Protection Agency (EPA) (23) . Ten replicates of the lowest concentration (0.5 ng/]0 lJL) in the working curve were analyzed by HS-SPME-GC, and the absolute amount of styrene and toluene recovered from each run was calculated using the standard working curve. The MDL was calculated as: MDL = SD x t (n -1, cz = 0.99), where n = number of replicate analyses; t = value from Student's t value at the 99% confidence interval; and SD = standard deviation value for 10 repeat analyses of the lowest standard on the calibration curve (0.5 ng/10 IJL). The MQL was calculated as 10 times the standard deviation of 10 repeat analyses of the 0.5 ng/10 IJL standard.
Relative recovery was evaluated using two standard concentrations of styrene and toluene, 10 and 100 ng/10 IJL, in various biological matrices. The absolute amount recovered from corresponding concentrations in serum, whole blood and phosphate buffer saline matrices were compared using Student's t-test. To evaluate the effect of interference of lipids in the sample matrix, a series of lipid emulsions of varying concentrations (1%, 5%, 10%, and 25%, w/w) were prepared by adding linoleic acid (99% purity) to serum. The lipid emulsions were homogenized by sonication at 20 MHz for 5 s. Concentrations of styrene and toluene emulsions at 10 and 100 ng in 10 IJL were prepared at room temperature by volumetric serial dilution of the 10 pg/mL intermediate standard in serum. The amount of styrene and toluene recovered from each lipid matrix was then compared using one-way analysis of variance (ANOVA) and the Bonferronni post-hoc test.
Because styrene and toluene are volatile, the loss of analytes during sample manipulation and sample handling was a concern. The rate of loss of analytes in response to exposure time of the samples to the laboratory atmosphere at room temperature was evaluated at target analyte concentrations of 1, 10, and 100 ng/]0 laL prepared in whole blood. A 10-tJL sample of standard stock was placed in a 10-mL SPME vial and exposed to the atmosphere for time intervals ranging from 10 to 120 s prior to closing the SPME vial. Triplicate determinations were made at each time point. Regression analysis was used to determine the rate of loss of analyte as a function of time.
Statistical analysis was performed using SPSS 15.0 for Windows (SPSS). Ap value less than 0.05 was considered statistically significant.
Results
Method development
Desorption time. The kinetics of thermal desorption of styrene and toluene from the SPME fiber were evaluated using 10 pL of the 1 ng/tJL standard in serum. During adsorption, the fiber was exposed to the HS of the vial for 4 min at room temperature. The depth of the fiber in the injection port of the GC was kept constant at 3.7 cm. Desorption times ranging from 15 to 120 s were investigated. As shown in Figure 1 orption times, larger amounts of styrene and toluene were detected. However, with an increase in desorption time, there was also a time-dependent peak broadening and tailing for toluene ( Figure 2 ). Therefore, to avoid errors in peak estimation, a desorption time of 30 s was chosen for all subsequent experiments.
Depth of the fiber in the injection port of the GC during desorption. The depth of the SPME fiber in the injection port of the GC during desorption was studied using 10 pL of the 1 ng/pL standard in serum. Adsorption was conducted at room temperature. The adsorption and desorption times were kept constant at 4 min and 30 s, respectively. The depth of the fiber was varied at 3.1, 3.3, 3.5, 3.7, and 3.9 cm using the depth adjustment gauge on the manual SPME fiber holder. As shown in Figure 3 , beyond a depth of 3.5 cm, no significant increase was ,_25 observed in the amount of analyte detected. Differences were evaluated statistically using the Student's t test. A p value less than 0.05 was considered statistically significant. Statistical comparison of styrene and toluene amounts recovered for the depth of the fiber pairs 3.1:3.3 cm and 3.3:3.5 cm yielded a p value of less than 0.05, and beyond 3.5 cm, the p value was greater than 0.05. The fiber depth of 3.7 cm in the injection port was chosen because this depth corresponds to the penetration depth of a 10-pL syringe needle when using the Agilent autosampler in the standard splitless mode. Adsorption time. The effect of adsorption time on detection of styrene and toluene in serum was studied using 10 pL of 1 ng/pL standard in serum. Desorption time and depth of the fiber in the injection port were kept constant at 30 s and 3.7 cm, respectively. At room temperature, the adsorption times investigated were 2, 4, 6, 10, and 15 min. Approximately 90% of the adsorption plateau value was reached at 4 min (Figure 4 ). An exposure time of 4 rain was chosen for subsequent experiments.
Adsorption temperature. The effect of temperature on adsorption was studied using 10 IJL of 10 and 0.5 ng/~L standards in serum. Temperatures ranging from room temperature (23~ to 60~ were investigated. The temperature was controlled using a heat block (Barnstead/Thermolyne, ~pe 17600). The adsorption and desorption times and depth of the fiber in the injection port during desorption were kept constant at 4 min, 30 s, and 3.7 cm, respectively. As shown in Figure 5 , no significant change in the amount of toluene or styrene recovered was observed with increase in temperature at either standard concentration. For subsequent studies, adsorption was performed at room temperature.
Sample volume. The effect of sample volume on recovery of styrene and toluene from serum was studied using sample concentrations 0.1 and 10 ng/IJL. Ten microliters of the standard stock was placed in an SPME vial and the appropriate volume of serum was added to prepare samples with a total volume ranging from 10 to 1000 ~L. The time of adsorption, desorption time, and depth of the fiber in the injection port during desorption were kept constant at 4 min, 30 s, and 3.7 cm, respectively. Adsorption was done at room temperature. The amount of toluene and styrene recovered was calculated using the standard curve. As seen in Figure 6 , no significant change in the amount of toluene and styrene recovered was observed by increasing sample volume using a 10-mL SPME vial.
Analytical method validation
Linearity. Linearity studies were conducted in serum and whole blood. The calibration curves obtained for styrene and toluene in serum and whole blood were linear in the range 0.05-50 ng/pL. Because 10 lJL of the standard concentration was used, the range of linearity can also be expressed as 0.5-500 ng/10 pL. Each standard concentration was analyzed in triplicate and the mean values were used for statistical analysis. Least square linear regression analysis was applied to estimate the slope, intercept, and regression coefficient of styrene and toluene in serum and whole blood. In spite of high regression coefficients (> 0.99), the whole range standard curve (0.5-500 ng/10 pL), owing to its high intercept, is unsuitable for measuring concentrations of styrene and toluene at the lower end of the curve. To ensure accuracy of quantitation at low concentrations, the 0.5-500 ng/10 IJL standard curve was truncated at 25 ng/10 lJL according to the Baadenhuijsen et al. method (24) .
The standard working curves of styrene and toluene in serum are shown in Figure 7 . The equation of the line for the whole range curve (0.5-500 ng/10 ~L) wasy = 1.94x-6.89 and y = 1.61x -1.84 for toluene and styrene, respectively. The equation of the line for the low range curve (0.5-25 ng/10 IJL) was y = 1.89x -0.21 and y = 1.74x + 0.04 for toluene and styrene, respectively. The standard working curves of styrene and toluene in whole blood are shown in Figure 8 . The equation of the line for the whole range curve (0.5-500 ng/10 pL) was y = 1.89x + 3.42 and y = 1.75x -2.24 for toluene and styrene, respectively. The equation of the line for the low range curve (0.5-25 ng/10 pL) wasy = 1.97x + 1.23 andy = 1.63x + 0.49 for toluene and styrene, respectively.
The calibration fitting (i.e., slope and intercept of styrene and toluene in both biological matrices) was similar. Paired t-tests between triplicate analysis of whole blood and serum at each standard curve concentration level indicates that there exists no significant difference between chromatographic peak areas obtained by HS-SPME-GC analysis of corresponding standard concentrations of styrene and toluene in whole blood and serum throughout the linear range (0.5-500 ng/10 pL). The % difference in slope for serum and whole blood was calculated as approximately 2% for toluene and 4.5% for styrene at the low concentration range (0.5-25 ng/10 IJL). Accuracy and precision. Intraday and interday precision and accuracy were calculated for three standard concentrations: 1, 10, and 100 ng/10 tJL. According to the EPA guidelines (29) , the precision and accuracy, expressed as %CV and % accuracy, should be 15% at all concentration levels, except at the MDL where it should not exceed 20%. The results are summarized in Table I . The mean values were within 10% of the expected values. For toluene and styrene, intraday and interday accuracy ranged from 3.15 to 10.11% and 1.25 to 4.62%, respectively. Intraday and interday precision expressed as % CV were less than 5% for both styrene and toluene. The method meets the criteria for both accuracy and precision as defined by the guidelines for bioanalytical method validation (29) .
Minimal detection and quantitation limit. MDL and MQL for the analytes, styrene, and toluene in whole blood and serum were determined using the protocol outlined by EPA guidelines (23) . Ten replicates of the lowest concentration (0.5 ng/10 IJL) in the working curve were analyzed by HS-SPME-GC and the absolute amount of styrene and toluene recovered from each
Table II. Recovery Studies in Different Matrices
Relative Recovery (%) Toluene Matrix 10 ng 100 ng 10 ng Styrene* run was calculated using the standard working curve. The MDL was calculated as MDL = SD x t (n-l, c~ = 0.99), where n = number of replicate analyses; t = value from Student's t value at the 99% confidence interval; and SD = standard deviation value for 10 repeat analyses of the lowest standard on the calibration curve (0.5 ng/10 IJL). The MQL was calculated as 10 times the standard deviation for 10 repeat analyses of the 0.5 ng/10 IJL standard. The MDL and MQL of toluene in serum were 0.08 and 0.28 ng/10 pL, respectively, and the MDL and MQL of styrene were 0.13 and 0.46 ng/10 IaL, respectively. The MDL and MQL of toluene in whole blood were 0.07 and 0.26 ng/10 IJL, and the MDL and MQL of styrene were 0.14 and 0.49 ng/10 IJL.
Relative recovery in different matrices and the interference of sample lipid content. The relative recoveries of styrene and toluene in whole blood, serum, saline, and a series of lipid emulsions of varying concentrations (1%, 5%, 10%, and 25%, w/w) at two standard concentrations, 100 and 10 ng/10 IJL, were calculated using the standard working curve in serum. Recoveries were calculated relative to serum with no additional lipid added. Statistics was done using SPSS. The results were compared by one-way ANOVA and the Bonferronni post-hoc test (p = 0.05). As seen in Table II Figure 9 , Effect of sample exposure on recovery of styrene and toluene.
The loss of styrene and toluene in whole blood as a function of time from a 10-pL sample was determined at the concentration level of 1 ng/10 pL. The 100% reference indicates the amount of styrene and toluene recovered from stock solution before exposing the sample to the atmosphere. Values shown are means of three independent readings, and the error bars indicate standard deviation.
handling was a concern. The loss of styrene and toluene in whole blood as a function of time from a 10-IJL sample in a 10-mL SPME vial at room temperature was determined at the three concentrations of 1, 10, and 100 ng/10 IJL. A 10-1JL aliquot of the whole blood standard was transferred to the SPME vial and exposed to the atmosphere for 0, 15, 30, 60, and 120 s prior to capping the vial. The amount of styrene and toluene recovered from the standard stock at the zero time exposure was used as the reference and percent recovery was calculated against it. The mean of triplicate analysis at each time point was used to construct the trend line. The trend line for the lowest concentration point studied 1 ng/10 IJL is shown in Figure 9 . Analyte half times were calculated by extrapolation of the trend line to 50% of the initial concentration. The styrene trend line equations were y = 99.2e-~176176 y = 99.5e -~176176 andy = 100e -~176176 for 1, 10, and 100 ng/10 I~L whole blood standard solutions, respectively. The toluene trend line equations were y = 98.3e -~176176 y = 98.3e -~176176 andy = 99.6e -~176176176 for 1, 10, and 100 ng/10 IJL whole blood standard solutions, respectively. Analyte half-times varied less than 20% over the three concentration ranges (Table III) .
Discussion
The apparent simplicity in sample preparation, applicability to small sample volumes, reliability, selectivity, sensitivity, and consequent reduction of cost and time of analysis has made this method an attractive tool for analyzing trace amounts of volatile organic compounds in biological samples. In this study, quantitative assessment of low concentrations of styrene and toluene in biological samples was carried out using HS-SPME-GC.
The adsorption and desorption kinetics were studied during method development. In the current method, exposure of the fiber to the HS of the sample vial for 4 rain results in 90% recovery of the total amount of styrene and toluene that can be extracted from the sample matrix at equilibrium. Additional sensitivity can be achieved by increasing the adsorption time at the cost of longer analysis time. Although SPME has maximum sensitivity at the equilibrium point, full equilibration is not essential for accuracy and precision. (25) . During optimization of desorption time, it was observed that although an increase in desorption time resulted in increased detection of styrene and toluene; it caused undesirable peak broadening and considerable tailing. Further enhancement of sensitivity might be achieved by modifying the method to include a low cryofocusing temperature during desorption. Watanabe-Suzuki et al. (26) developed a simple and sensitive method for the determination of styrene, toluene, ethyl benzene, and other volatile compounds in human body fluids using cryogenic oven trapping and capillary GC.
Pharmacokinetic studies have shown that following absorption, toluene and styrene are rapidly distributed in the body and the highest levels are observed in the adipose tissue (27, 28) . In the current study, the effect of increasing serum lipid levels on toluene and styrene recovery was evaluated. No adverse effect on toluene and styrene recovery was observed up to a serum lipid content of 25% and 10% for toluene and styrene, respectively. The study does suggest that for matrices with high lipid content, greater than 25% for toluene and 10% for styrene, recovery may be adversely affected. For fatty matrices, such as brain and adipose tissue, further investigation is required prior to application of this method to these matrices.
The volume of sample and sample surface area play important roles in evaporation kinetics during HS-SPME analysis. The rate of toluene and styrene loss determined in this study is applicable only to the 10-laL sample in a 10-mL SPME vial. As shown in Figure 9 and Table III , fairly rapid loss of analytes is observed in the 10-laL Analyte sample. Because the rate of analyte loss is Toluene fairly rapid, care must be taken to limit exposure time. In our laboratory, blood draws are Toluene made directly into capillary tubes and dissected tissue is transferred to capped SPME Toluene vials within 10 s. Exposure studies indicate Toluene that over 95% of the analytes were recovered Toluene from a 1 ng/10 laL whole blood standard after Toluene a 10 s exposure to the atmosphere (Figure 9 ).
The advantage of this method is in its appli-Styrene cability to small sample volumes. While previ-ously developed methods using LLE, HS, and HS-SPME use sample volumes ranging from 0.5 to 5 mL (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) , our method is applicable to sample volumes as low as 10 laL of whole blood, 2 laL of perilymph, and approximately 0.4 mg of cochlear tissue.
In Table IV , the sample volume and minimal detection limits of previously developed HS-SPME methods are listed. An important factor driving the detection limit is the amount of sample available for analysis. In comparing the current method with previously established methods, we have normalized MDL for all methods to a 10-laL sample volume (Table IV) . Most methods have considerable higher MDL than the current method, with the exception of the Fustinoni et al. (11) method, which uses a simpler biological matrix (namely, urine) and measures only toluene.
The method developed in this paper has been successfully used by Chen et al. (22) in studying the mechanism of hearing loss in rats exposed to styrene by gavage. In that study, HS-SPME-GC was used to determine the distribution of styrene in cochlea and the kinetics of styrene in blood as a function of time after exposure. The kinetics of styrene in blood samples was determined after as single oral gavage of 800 mg/kg. The styrene concentration in blood ranged from 18.2 to 22.9 lag/g over a period of 6 h after dosing. Similar levels were obtained with repeated daily dosing over 6 days. Blood levels returned to baseline within 24 h after dosing. Perilymph samples from isolated cochleae at this dose averaged 3.1 + 0.6 lag/g. Cochlear tissue exhibited decreasing styrene concentrations from the apical turn at 12.5 + 3.0 lag/g, to the middle turn at 7.4 + 1.6 lag/g to the basal turn at 4.8 + 1.0 lag/g in animals receiving the same dose. 
